Answer
The most frequent adverse effects of intravenous remimazolam besylate in procedural sedation are hypotension (37.2%), respiratory depression (13.1%) and bradycardia (6.8%).
Sources for this answer
- Byfavo 20mg powder for solution for injectionPAION UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked